Cologne, Germany, April 11, 2013. Direvo Industrial Biotechnology GmbH has joined a group of stakeholders from the biobased industry contributing to BRIDGE, a European Commission public- private partnership (PPP). BRIDGE stands for „Biobased and Renewable Industries for Development and Growth in Europe?. The aim is to foster biobased industrial development in Europe by bridging the gap from research to the marketplace. Direvo is the only Small and Medium Enterprise (SME) from Europe which is directly engaged in the BRIDGE PPP.
BIC, a Biobased Industries Consortium, has already made available 2.8 billion EUR for the PPP. This amount shall be complemented by 1 billion EUR from the European Research Funding. The final decision about program and budget is expected to be made at the end of this year.
The PPP is being established in cooperation of the European Commission and the biobased industry as an integrated and fundamental tool under Horizon 2020, the 8th EU framework program aimed at securing Europe?s global competitiveness, and the Strategy and Action Plan for Sustainable Bioeconomy in Europe. The industry is organized in a consortium including more than 40 European companies and organizations across technology, industry, agriculture and forestry, among them Novozymes, DSM, Clariant and Unilever. The consortium was established on February 28, 2013 in Brussels.
“It is important for Europe to bring together its most innovative companies and clusters under one roof to boost a truly biobased economy. With great pleasure and pride, Direvo engages in this Partnership.” said Jorg Riesmeier, CEO of Direvo. “Our research platform BluCon® for the transformation of cellulosic biomass to valuable chemicals and our BluServ™ Service Portfolio for tailor-made biobased solutions will surely enrich this consortium.”
About BRIDGE:
BRIDGE is a Public Private Partnership between the European Commission and biobased industries and stands for „Biobased and Renewable Industries for Development and Growth in Europe?. To strengthen Europe as a competitive, innovative and sustainable economy, BRIDGE will focus on three different areas of activities:
1. Building new biobased value chains based on the development of sustainable biomass collection and supply systems with increased productivity, and improved utilization of biomass feedstock.
2. Bringing existing value chains to new levels, through optimized uses of feed and industrial side- streams, and offering new added value products to market.
3. Bringing technology to maturity through research and innovation, and trough upgrading and building demonstration and flagship biorefineries.
More Information on BRIDGE can be found at www.bridge2020.eu.
About Direvo Industrial Biotechnology GmbH:
Direvo is a biotechnology company with focus on the biomass conversion industry. Direvo identifies bottlenecks and weaknesses in current industrial processes in this sector and develops and implements biology-based solutions together with large and small industrial partners. Direvo?s products are newly designed enzymes and microorganisms of the highest quality that provide easy-to- implement, cost-effective solutions. Direvo?s contribution assures that partners stay competitive and profitable while supporting them to make the future cleaner, greener and safer. More information about Direvo is available on www.direvo.com.
Contact:
Dr. Albrecht Läufer
DIREVO Industrial Biotechnology GmbH
Nattermannallee 1
50829 Köln (Cologne)
Germany
Phone +49 221-47448-108
Fax +49 221-47448-111
E-Mail albrecht.laeufer@direvo.com
Internet www.direvo.com
